BR112013027413A2 - vancomicina lipossomal para o tratamento de infecções de sarm. - Google Patents

vancomicina lipossomal para o tratamento de infecções de sarm.

Info

Publication number
BR112013027413A2
BR112013027413A2 BR112013027413A BR112013027413A BR112013027413A2 BR 112013027413 A2 BR112013027413 A2 BR 112013027413A2 BR 112013027413 A BR112013027413 A BR 112013027413A BR 112013027413 A BR112013027413 A BR 112013027413A BR 112013027413 A2 BR112013027413 A2 BR 112013027413A2
Authority
BR
Brazil
Prior art keywords
sarm
infections
treatment
liposomal vancomycin
vancomycin
Prior art date
Application number
BR112013027413A
Other languages
English (en)
Inventor
Omri Abdel
Y Liu George
Sande Linette
Original Assignee
Cedars Sinai Medical Center
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cedars Sinai Medical Center filed Critical Cedars Sinai Medical Center
Publication of BR112013027413A2 publication Critical patent/BR112013027413A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/14—Peptides containing saccharide radicals; Derivatives thereof, e.g. bleomycin, phleomycin, muramylpeptides or vancomycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BR112013027413A 2011-04-26 2012-04-26 vancomicina lipossomal para o tratamento de infecções de sarm. BR112013027413A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161479305P 2011-04-26 2011-04-26
PCT/US2012/035134 WO2012149116A2 (en) 2011-04-26 2012-04-26 Liposomal vancomycin for the treatment of mrsa infections

Publications (1)

Publication Number Publication Date
BR112013027413A2 true BR112013027413A2 (pt) 2019-09-24

Family

ID=47073061

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112013027413A BR112013027413A2 (pt) 2011-04-26 2012-04-26 vancomicina lipossomal para o tratamento de infecções de sarm.

Country Status (10)

Country Link
US (1) US20140205654A1 (pt)
EP (1) EP2701685A4 (pt)
JP (1) JP2014523859A (pt)
CN (1) CN104159571A (pt)
BR (1) BR112013027413A2 (pt)
CA (1) CA2834353A1 (pt)
MX (1) MX2013012603A (pt)
RU (1) RU2013147703A (pt)
WO (1) WO2012149116A2 (pt)
ZA (1) ZA201308806B (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110559423A (zh) * 2019-09-03 2019-12-13 四川农业大学 百里香酚在制备治疗生物被膜感染药物中的应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4978654A (en) * 1984-04-16 1990-12-18 Board Of Regents, The University Of Texas System Composition and method for treatment of disseminated fungal infections in mammals
US4818537A (en) * 1986-10-21 1989-04-04 Liposome Technology, Inc. Liposome composition for treating dry eye
CA2095410C (en) * 1993-05-03 1999-04-13 Madeleine Ravaoarinoro Production and characteristics of anti-teicoplanin polyclonal antibody
US6761901B1 (en) * 2000-05-02 2004-07-13 Enzrel Inc. Liposome drug delivery
GB0111279D0 (en) * 2001-05-10 2001-06-27 Nycomed Imaging As Radiolabelled liposomes
UA86063C2 (ru) * 2004-05-03 2009-03-25 Хермес Біосайенсез, Інк. Липосомы для снабжения лекарств
US20110033522A1 (en) * 2007-09-26 2011-02-10 Dana-Farber Cancer Institute, Inc. Reagents for inducing an immune response
AU2008316841B2 (en) * 2007-10-23 2014-04-17 Insmed Incorporated Liposomal vancomycin formulations
WO2010117996A1 (en) * 2009-04-08 2010-10-14 Children's Medical Center Corporation Prolonged duration local anesthesia with minimal toxicity
JP2013529638A (ja) * 2010-06-19 2013-07-22 ウェスタン ユニバーシティ オブ ヘルス サイエンス Ｐｅｇ化リポソーム封入糖ペプチド抗生物質の新規製剤

Also Published As

Publication number Publication date
ZA201308806B (en) 2014-08-27
EP2701685A2 (en) 2014-03-05
CN104159571A (zh) 2014-11-19
JP2014523859A (ja) 2014-09-18
EP2701685A4 (en) 2015-04-01
WO2012149116A2 (en) 2012-11-01
WO2012149116A3 (en) 2014-05-08
RU2013147703A (ru) 2015-06-10
MX2013012603A (es) 2014-04-25
CA2834353A1 (en) 2012-11-01
US20140205654A1 (en) 2014-07-24

Similar Documents

Publication Publication Date Title
LTC2785706I2 (lt) Pakeistieji 4-fenil-piridinai, skirti su nk-receptoriumi susijusių ligų gydymui
ES2898695T8 (es) Derivados de benzoxaborol para el tratamiento de infecciones bacterianas
CO6821964A2 (es) Compuestos para el tratamiento de la adicción
CO6930366A2 (es) Método para el tratamiento de vhc
EP3030323A4 (en) Kdm1a inhibitors for the treatment of disease
CO6791602A2 (es) Métodos y sistemas para el tratamiento de pozos
BR112015002524A2 (pt) derivados de alquilpirimidina para o tratamento de infecções virais e outras doenças.
DK2852391T3 (da) Systemer til behandling af lungeinfektioner
CO6811873A2 (es) Compuesto de dihidroisoxazol parasiticida
BR112013014943A2 (pt) compostos úteis para o tratamento de aids
CO6940432A2 (es) Compuestos de 1-arilcarbonilo-4-oxi-piperidina útiles para el tratamiento de enfermedades neurodegenerativas
BRDI7106210S (pt) Configuração aplicada para lâmina para microscópio
ES2603028T8 (es) Procedimiento para la preparación de (Z)-alfa-fluoro-beta-amino-acrilaldehídos sustituidos
DK2787841T3 (da) Beta-lactoglobulin-peptid til behandling komælksproteinallergi
ES2547827T8 (es) Procedimiento para la purificación de la micafungina
CL2013002908A1 (es) Uso de compuestos derivados de bencimidazol-4-carboxamida para el tratamiento profilactico de la neuropatia periferica inducida por quimioterapia .
CL2014001883A1 (es) Compuestos y métodos para el tratamiento de las infecciones de candidiasis y aspergillus
CO6821965A2 (es) 1-piperazino-3-fenil-indanos deuterados para el tratamiento de esquizofrenia
BR112014017519A2 (pt) peptídeos sintéticos para tratamento de infecções bacterianas
BR112014012759A8 (pt) composto, composição e método para tratamento
BR112015005627A2 (pt) composto, composição farmacêutica, uso de composto, método de tratamento e invenção.
BR112014016122A8 (pt) composto, e, composição farmacêutica
BR112013030930A2 (pt) composições farmacêuticas combinadas para o tratamento de tumores
BR112013020866A2 (pt) combinações de compostos ativos
ES2389362B1 (es) Extension para el cabello y metodo para su aplicacion.

Legal Events

Date Code Title Description
B08F Application fees: dismissal - article 86 of industrial property law
B08K Lapse as no evidence of payment of the annual fee has been furnished to inpi (acc. art. 87)

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2543 DE 01-10-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.